What is Valkee?
Valkee is a pioneering health technology company that leverages the therapeutic benefits of bright light for the human mind and performance. Building on extensive scientific research and development in collaboration with Finland's Oulu University, Valkee launched the world's first bright light headset in 2010. The device has demonstrated clinical efficacy in alleviating seasonal affective disorder symptoms in a significant majority of users. With a growing global user base across more than 20 countries, Valkee continues to explore the broader applications of bright light, including cognitive and physical performance enhancement, and jet lag mitigation.
How much funding has Valkee raised?
Valkee has raised a total of $9.7M across 1 funding round:
Series A
$9.7M
Series A (2013): $9.7M, investors not publicly disclosed
What's next for Valkee?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for Valkee. This capital infusion is expected to accelerate product development, expand market reach, and further validate the scientific underpinnings of their bright light technology. Future initiatives will likely focus on broader clinical studies and scaling operations to meet increasing global demand for non-pharmacological wellness solutions.
See full Valkee company page
